赤天化(600227) - 2024 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2024 was ¥437,342,800.21, representing a decrease of 11.77% compared to the same period last year[5]. - The net profit attributable to shareholders was -¥40,180,722.94, indicating a significant loss due to the operational challenges faced by the company[5]. - The net cash flow from operating activities was -¥19,046,680.96, reflecting a decrease in cash payments for goods and services[5]. - Total operating revenue for Q1 2024 was ¥437,342,800.21, a decrease of 11.7% compared to ¥495,668,175.06 in Q1 2023[17]. - Net loss for Q1 2024 was ¥40,180,722.94, compared to a net loss of ¥35,928,727.03 in Q1 2023, indicating a worsening of 11.5%[18]. - The company's cash flow from operating activities in Q1 2024 was ¥402,579,874.80, down from ¥441,388,329.01 in Q1 2023[20]. - The basic and diluted earnings per share for Q1 2024 were both -¥0.0237, compared to -¥0.0205 in Q1 2023[18]. - The company reported a tax expense of ¥675,291.52 in Q1 2024, contrasting with a tax benefit of -¥5,222,637.39 in Q1 2023[18]. - The total comprehensive income for Q1 2024 was -¥8,067,605.31, compared to -¥15,083,053.79 in Q1 2023, reflecting a year-over-year improvement of 46.51%[29]. Assets and Liabilities - Total assets at the end of Q1 2024 were ¥4,784,364,600.80, an increase of 1.01% from the end of the previous year[6]. - The total liabilities as of Q1 2024 were ¥2,152,701,743.99, a slight decrease from ¥2,064,861,192.19 in Q1 2023[14]. - The total equity attributable to shareholders was ¥2,631,662,856.81 in Q1 2024, down from ¥2,671,655,642.60 in Q1 2023[14]. - The total current assets as of March 31, 2024, amounted to RMB 870,861,510.95, an increase from RMB 797,438,348.85 as of December 31, 2023, reflecting a growth of approximately 9.2%[12]. - Total non-current assets as of March 31, 2024, were RMB 3,913,503,089.85, down from RMB 3,939,078,485.94, a decrease of approximately 0.6%[13]. - The total assets as of March 31, 2024, amounted to 3,240,538,351.84 RMB, a decrease from 3,271,049,997.05 RMB at the end of 2023[25]. - The total liabilities decreased to 411,508,578.98 RMB from 432,703,083.22 RMB in the previous year[26]. Cash Flow and Investments - The net cash flow from operating activities for Q1 2024 was -19,046,680.96 RMB, compared to -49,488,943.71 RMB in Q1 2023, indicating an improvement in cash flow[21]. - The net cash flow from investing activities was -87,416,471.64 RMB, compared to -100,614,166.23 RMB in Q1 2023, showing a reduction in cash outflow[21]. - The company's cash outflow from investing activities in Q1 2024 was ¥52,324,041.56, compared to ¥36,400,000.00 in Q1 2023, indicating an increase of 43.69%[32]. - The company’s net increase in cash and cash equivalents for Q1 2024 was -82,403,536.40 RMB, compared to -13,265,929.38 RMB in Q1 2023[22]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 54,297, with the largest shareholder holding 26.44% of the shares[10]. - The company has not reported any significant changes in its major shareholders or their shareholdings during the reporting period[11]. Operational Challenges - The decline in operating revenue was primarily attributed to a decrease in the selling prices of chemical products, specifically urea and compound fertilizers[8]. - The company reported that the formal operation of Daqin Hospital contributed to increased losses compared to the same period last year, as it was in the preparation stage previously[8]. Expenses - Research and development expenses increased to ¥17,680,650.57 in Q1 2024, up 34.5% from ¥13,131,988.47 in Q1 2023[17]. - Financial expenses rose significantly to ¥14,610,603.25 in Q1 2024, compared to ¥5,412,714.23 in Q1 2023, reflecting an increase of 170.5%[17]. - The company incurred financial expenses of ¥976,173.16 in Q1 2024, an increase of 23.25% compared to ¥791,768.69 in Q1 2023[29]. - The company reported a decrease in management expenses to ¥8,706,167.50 in Q1 2024 from ¥12,113,489.84 in Q1 2023, a reduction of 28.88%[29]. - The interest expenses for Q1 2024 were ¥897,260.00, down from ¥1,010,650.00 in Q1 2023, indicating a decrease of 11.16%[29].